Figure 3 | Scientific Reports

Figure 3

From: Therapeutic potential of fibrinogen γ-chain peptide-coated, ADP-encapsulated liposomes as a haemostatic adjuvant for post-cardiopulmonary bypass coagulopathy

Figure 3

Results of ELISA employed to assess coagulation function, platelet activation, and systemic inflammation. (A) Fibrinogen concentration (mg/dL). (B) Concentration of β-thromboglobulin (β-TG) (ng/mL). (C) Concentration of platelet factor 4 (PF4) (ng/mL). (D) Concentration of IL-6 (ng/mL). Data represent mean ± standard deviation from five mice in the PPP and H12-ADP-liposome/PPP groups and eight mice in the PRP and H12-ADP-liposome/PRP groups.

Back to article page